These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 11077624)

  • 1. Estrogen, progesterone and the gastrointestinal tract.
    Eliakim R; Abulafia O; Sherer DM
    J Reprod Med; 2000 Oct; 45(10):781-8. PubMed ID: 11077624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of hormone replacement therapy on sleep-disordered breathing in postmenopausal women: a pilot study.
    Manber R; Kuo TF; Cataldo N; Colrain IM
    Sleep; 2003 Mar; 26(2):163-8. PubMed ID: 12683475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex hormone replacement therapy and modulation of vascular function in cardiovascular disease.
    Koledova VV; Khalil RA
    Expert Rev Cardiovasc Ther; 2007 Jul; 5(4):777-89. PubMed ID: 17605655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
    Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
    Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of estrogen and progesterone on asthma.
    Haggerty CL; Ness RB; Kelsey S; Waterer GW
    Ann Allergy Asthma Immunol; 2003 Mar; 90(3):284-91; quiz 291-3, 347. PubMed ID: 12669890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postmenopausal hormone replacement therapy: endometrial and breast effects.
    Yeh IT
    Adv Anat Pathol; 2007 Jan; 14(1):17-24. PubMed ID: 17198307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen, progestogens and cardiovascular risk.
    Stefanick ML
    J Reprod Med; 1999 Feb; 44(2 Suppl):221-6. PubMed ID: 11392036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ischemic colitis in postmenopausal women taking hormone replacement therapy.
    Zervoudis S; Grammatopoulos T; Iatrakis G; Katsoras G; Tsionis C; Diakakis I; Calpaktsoglou C; Zafiriou S
    Gynecol Endocrinol; 2008 May; 24(5):257-60. PubMed ID: 18569029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of transdermal and oral estrogen/progesterone regimens on free and total protein S in postmenopausal women.
    Marque V; Alhenc-Gelas M; Plu-Bureau G; Oger E; Scarabin PY
    Thromb Haemost; 2001 Aug; 86(2):713-4. PubMed ID: 11522028
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative cardiovascular effects of different progestins in menopause.
    Rosano GM; Fini M
    Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective modulation of postmenopausal women: cutting the Gordian knot of hormone replacement therapy with breast carcinoma.
    Diamanti-Kandarakis E; Sykiotis GP; Papavassiliou AG
    Cancer; 2003 Jan; 97(1):12-20. PubMed ID: 12491500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of transdermal and oral estrogen replacement on lipids and glucose metabolism in postmenopausal women with type 2 diabetes mellitus.
    Araújo DA; Farias ML; Andrade AT
    Climacteric; 2002 Sep; 5(3):286-92. PubMed ID: 12419087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The influence of hormonal replacement therapy on bone density in postmenopausal women depending on polymorphism of vitamin D receptor (VDR) and estrogen receptor (ER) genes].
    Brodowska A
    Ann Acad Med Stetin; 2003; 49():111-30. PubMed ID: 15552843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of estrogen/progesterone hormone replacement therapy on natural killer cell cytotoxicity and immunoregulatory cytokine release by peripheral blood mononuclear cells of postmenopausal women.
    Stopińska-Głuszak U; Waligóra J; Grzela T; Głuszak M; Jóźwiak J; Radomski D; Roszkowski PI; Malejczyk J
    J Reprod Immunol; 2006 Feb; 69(1):65-75. PubMed ID: 16236362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of different hormonal replacement therapies on circulating allopregnanolone and dehydroepiandrosterone levels in postmenopausal women.
    Bernardi F; Pieri M; Stomati M; Luisi S; Palumbo M; Pluchino N; Ceccarelli C; Genazzani AR
    Gynecol Endocrinol; 2003 Feb; 17(1):65-77. PubMed ID: 12724021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of low-dose, continuous combined hormone replacement therapy on sleep in symptomatic postmenopausal women.
    Gambacciani M; Ciaponi M; Cappagli B; Monteleone P; Benussi C; Bevilacqua G; Vacca F; Genazzani AR
    Maturitas; 2005 Feb; 50(2):91-7. PubMed ID: 15653005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of hormone replacement therapy to estrogen and progesterone receptor status in invasive breast carcinoma.
    Chen WY; Hankinson SE; Schnitt SJ; Rosner BA; Holmes MD; Colditz GA
    Cancer; 2004 Oct; 101(7):1490-500. PubMed ID: 15378477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogens and the skin.
    Brincat MP; Baron YM; Galea R
    Climacteric; 2005 Jun; 8(2):110-23. PubMed ID: 16096167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Could transdermal estradiol + progesterone be a safer postmenopausal HRT? A review.
    L'hermite M; Simoncini T; Fuller S; Genazzani AR
    Maturitas; 2008; 60(3-4):185-201. PubMed ID: 18775609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hormone replacement therapy of menopause, heart and blood vessels].
    Kuttenn F; Gerson M
    Arch Mal Coeur Vaiss; 2001 Jul; 94(7):685-9. PubMed ID: 11494629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.